ReviewOncotarget2023

HER3- A key survival pathway and an emerging therapeutic target in metastatic colorectal cancer and pancreatic ductal adenocarcinoma.

Omkar Desai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.